IL22 and cancer: Interestingly, Il22, largely expressed by pretumorigenic cells, is one of the few genes downregulated in expression in TGFβR-KO mice compared to in TGFβR-WT mice, suggesting that lower levels of Il22 expression by TGFβR-KO pretumorigenic T cells may contribute to cancer progression once dsDNA damage is generated.